A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.
The Scientist
Most Recent
A new study reveals a large mix of microbes in most human belly buttons.
The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.
Inflammatory signals in injured zebrafish brains promote the growth of new neurons.
A third dose of the MMR vaccine given during an intense outbreak appears to have provided herd-immunity to control the spread of the disease.
The European Commission approves the Western hemisphere’s first gene therapy, aimed at correcting a lipid-processing disorder.
Successive awakening of soil microbes drives a huge pulse of CO2 following the first rain after a dry summer.
After two headline successes, companies rush to develop “smart bomb” cancer drugs.
Understanding the mechanism of a classic tuberculosis treatment could refine future strategies for TB drug development.
Mice fed a mix of six strains of bacteria were able to fight a C. difficile infection that causes deadly diarrhea and is resistant to most types of treatment.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
